Mr. Anderson has done groundbreaking work in the area of clinical research metrics. He has developed sustainable metrics programs for various clients that measure both costs and productivity in the conduct of clinical trials. He has also developed cost/benefit and ROI models for enterprise software acquisition at multinational biopharmas.

Mr. Anderson has worked on multiple NDA and EU submissions, participating in the planning and execution of SAS programming for CSRs and integrated safety summary reporting. He and other W&A staff have also managed projects that extract, transpose and deliver study-level data into Clinical Data Warehouses for inclusion into statistical programming efforts and submission of new product registrations. He and other W&A staff have direct experience in the use of typical CDW tools such as SAS Drug Discovery and JReview, and is also familiar with ODM and SDTM data models and their downstream use by statisticians, either as SDTM or ADaM data sets.

Previously Mr. Anderson was a Project Manager at Technilogix, Inc., a second generation EDC provider. Before that, he spent five years with Eli Lilly and Company, designing various clinical data systems to support all aspects of the clinical trial process. In addition, Mr. Anderson worked at the Lilly German affiliate, where he was European project manager for the design and implementation of a worldwide electronic data capture system.

Mr. Anderson has a B.S. in computer science and mathematics from Grand Valley State University in Allendale, Michigan. He is fluent in German and staffs our Research Triangle Park, NC office. Mr. Anderson has contributed to various industry publications and is a frequent presenter at industry meetings.